Daniel Schwartz
Ophthalmology · San Francisco, CANPI 1740392901
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,851,671 of the $7,980,561 with a category attached, or 98.4%. Rxsight Inc accounts for 100.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $7,852,269 and has fallen 100.0% since, to $431 in 2025. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $199,514 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$8M
- Carl Zeiss Meditec, Inc.$168
- Genentech USA, Inc.$114
- Alcon$58
- AbbVie$24
- Regeneron$20
- plus $15 from 1 others
Across 1 payment — averaging $30,325 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coopervision Inc.$30K
What the payments were for
- Consulting fees$126,5252%
- Speaking & faculty fees$7,851,67198%
- Travel & lodging$1,6530%
- Food & beverage$7130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 31 | $7,980,163 |
| Carl Zeiss Meditec, Inc. | 1 | $168 |
| Genentech USA, Inc. | 4 | $114 |
| Alcon | 1 | $58 |
| AbbVie | 1 | $24 |
| Regeneron | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$7,852,485
- RXSIGHT INJECTOR CARTRIDGE$7,852,485
- RXSIGHT INJECTOR HANDPIECE$7,852,485
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$7,852,485
- LIGHT ADJUSTABLE LENS (LAL)$7,852,335
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$44,750
- VERACITY SURGICAL$168
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$150
How this compares
$7,980,561 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in San Francisco
- Gaurav ShahSan Francisco$620K
- Shan LinSan Francisco$374K
- H TanakaSan Francisco$238K
- Jay StewartSan Francisco$219K
- Scott SoSan Francisco$173K
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.